1. Home
  2. IBG vs MTNB Comparison

IBG vs MTNB Comparison

Compare IBG & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBG
  • MTNB
  • Stock Information
  • Founded
  • IBG 2018
  • MTNB 2013
  • Country
  • IBG Australia
  • MTNB United States
  • Employees
  • IBG N/A
  • MTNB N/A
  • Industry
  • IBG Beverages (Production/Distribution)
  • MTNB Biotechnology: Pharmaceutical Preparations
  • Sector
  • IBG Consumer Staples
  • MTNB Health Care
  • Exchange
  • IBG Nasdaq
  • MTNB Nasdaq
  • Market Cap
  • IBG 4.1M
  • MTNB 3.6M
  • IPO Year
  • IBG 2024
  • MTNB N/A
  • Fundamental
  • Price
  • IBG $0.54
  • MTNB $0.93
  • Analyst Decision
  • IBG Strong Buy
  • MTNB Hold
  • Analyst Count
  • IBG 1
  • MTNB 1
  • Target Price
  • IBG N/A
  • MTNB N/A
  • AVG Volume (30 Days)
  • IBG 130.1K
  • MTNB 379.6K
  • Earning Date
  • IBG 06-17-2025
  • MTNB 05-15-2025
  • Dividend Yield
  • IBG N/A
  • MTNB N/A
  • EPS Growth
  • IBG N/A
  • MTNB N/A
  • EPS
  • IBG N/A
  • MTNB N/A
  • Revenue
  • IBG $2,931,243.00
  • MTNB N/A
  • Revenue This Year
  • IBG N/A
  • MTNB N/A
  • Revenue Next Year
  • IBG N/A
  • MTNB N/A
  • P/E Ratio
  • IBG N/A
  • MTNB N/A
  • Revenue Growth
  • IBG N/A
  • MTNB N/A
  • 52 Week Low
  • IBG $0.44
  • MTNB $0.47
  • 52 Week High
  • IBG $3.35
  • MTNB $9.60
  • Technical
  • Relative Strength Index (RSI)
  • IBG N/A
  • MTNB 68.54
  • Support Level
  • IBG N/A
  • MTNB $0.77
  • Resistance Level
  • IBG N/A
  • MTNB $0.96
  • Average True Range (ATR)
  • IBG 0.00
  • MTNB 0.12
  • MACD
  • IBG 0.00
  • MTNB 0.01
  • Stochastic Oscillator
  • IBG 0.00
  • MTNB 45.43

About IBG Innovation Beverage Group Limited Ordinary Shares

Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands.

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Share on Social Networks: